Cipher Pharmaceuticals Stock Price History
CPH Stock | CAD 14.87 0.05 0.34% |
Below is the normalized historical share price chart for Cipher Pharmaceuticals extending back to February 25, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cipher Pharmaceuticals stands at 14.87, as last reported on the 11th of December 2024, with the highest price reaching 15.23 and the lowest price hitting 13.85 during the day.
If you're considering investing in Cipher Stock, it is important to understand the factors that can impact its price. Cipher Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0591, which signifies that the company had a -0.0591% return per unit of risk over the last 3 months. Cipher Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cipher Pharmaceuticals' Standard Deviation of 3.91, risk adjusted performance of (0.03), and Mean Deviation of 2.77 to double-check the risk estimate we provide.
At this time, Cipher Pharmaceuticals' Total Stockholder Equity is very stable compared to the past year. As of the 11th of December 2024, Common Stock Shares Outstanding is likely to grow to about 32.1 M, while Liabilities And Stockholders Equity is likely to drop about 46.4 M. . At this time, Cipher Pharmaceuticals' Price Earnings To Growth Ratio is very stable compared to the past year. As of the 11th of December 2024, Price To Operating Cash Flows Ratio is likely to grow to 6.98, while Price To Sales Ratio is likely to drop 4.78. Cipher Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 11.676 | 50 Day MA 15.3748 | Beta 1.174 |
Cipher |
Sharpe Ratio = -0.0591
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | CPH |
Estimated Market Risk
4.0 actual daily | 35 65% of assets are more volatile |
Expected Return
-0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cipher Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cipher Pharmaceuticals by adding Cipher Pharmaceuticals to a well-diversified portfolio.
Price Book 2.8649 | Enterprise Value Ebitda 25.3728 | Price Sales 15.1442 | Shares Float 14.5 M | Wall Street Target Price 16.7 |
Cipher Pharmaceuticals Stock Price History Chart
There are several ways to analyze Cipher Stock price data. The simplest method is using a basic Cipher candlestick price chart, which shows Cipher Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 11, 2024 | 17.89 |
Lowest Price | November 13, 2024 | 12.71 |
Cipher Pharmaceuticals December 11, 2024 Stock Price Synopsis
Various analyses of Cipher Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cipher Stock. It can be used to describe the percentage change in the price of Cipher Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cipher Stock.Cipher Pharmaceuticals Accumulation Distribution | 10,721 | |
Cipher Pharmaceuticals Price Daily Balance Of Power | (0.04) | |
Cipher Pharmaceuticals Price Rate Of Daily Change | 1.00 | |
Cipher Pharmaceuticals Price Action Indicator | 0.30 |
Cipher Pharmaceuticals December 11, 2024 Stock Price Analysis
Cipher Stock Price History Data
The price series of Cipher Pharmaceuticals for the period between Thu, Sep 12, 2024 and Wed, Dec 11, 2024 has a statistical range of 5.51 with a coefficient of variation of 8.13. The prices are distributed with arithmetic mean of 15.44. The median price for the last 90 days is 15.35.Open | High | Low | Close | Volume | ||
12/11/2024 | 14.50 | 15.23 | 13.85 | 14.87 | 118,314 | |
12/10/2024 | 15.85 | 16.03 | 14.16 | 14.92 | 114,555 | |
12/09/2024 | 16.29 | 16.29 | 15.37 | 15.66 | 60,731 | |
12/06/2024 | 16.02 | 16.05 | 15.72 | 16.00 | 15,634 | |
12/05/2024 | 15.97 | 16.33 | 15.75 | 15.75 | 38,357 | |
12/04/2024 | 15.54 | 15.97 | 15.54 | 15.76 | 31,703 | |
12/03/2024 | 15.50 | 15.87 | 15.30 | 15.60 | 30,975 | |
12/02/2024 | 15.40 | 15.65 | 15.09 | 15.29 | 23,173 | |
11/29/2024 | 15.15 | 15.35 | 14.81 | 15.35 | 14,158 | |
11/28/2024 | 14.77 | 15.08 | 14.72 | 14.99 | 13,987 | |
11/27/2024 | 14.40 | 14.75 | 14.36 | 14.75 | 17,069 | |
11/26/2024 | 14.32 | 14.42 | 14.00 | 14.40 | 30,183 | |
11/25/2024 | 14.90 | 14.90 | 14.24 | 14.24 | 40,641 | |
11/22/2024 | 14.46 | 14.89 | 14.23 | 14.86 | 44,363 | |
11/21/2024 | 14.74 | 14.74 | 14.29 | 14.56 | 18,012 | |
11/20/2024 | 14.78 | 14.87 | 14.50 | 14.72 | 30,111 | |
11/19/2024 | 14.50 | 14.69 | 14.25 | 14.65 | 36,053 | |
11/18/2024 | 14.27 | 14.67 | 13.68 | 14.50 | 69,767 | |
11/15/2024 | 13.80 | 13.94 | 13.34 | 13.67 | 85,179 | |
11/14/2024 | 13.17 | 14.31 | 13.16 | 13.80 | 128,705 | |
11/13/2024 | 13.05 | 13.30 | 12.60 | 12.71 | 111,554 | |
11/12/2024 | 12.54 | 13.43 | 12.54 | 12.80 | 141,000 | |
11/11/2024 | 13.79 | 14.26 | 12.70 | 12.79 | 134,194 | |
11/08/2024 | 15.16 | 15.17 | 13.88 | 13.88 | 177,019 | |
11/07/2024 | 15.24 | 15.56 | 15.06 | 15.54 | 72,378 | |
11/06/2024 | 14.96 | 15.15 | 14.30 | 15.04 | 72,266 | |
11/05/2024 | 14.99 | 15.33 | 14.75 | 14.75 | 19,197 | |
11/04/2024 | 15.00 | 15.21 | 14.93 | 15.11 | 25,200 | |
11/01/2024 | 15.15 | 15.46 | 15.15 | 15.24 | 19,279 | |
10/31/2024 | 15.55 | 15.55 | 14.87 | 15.04 | 45,088 | |
10/30/2024 | 15.55 | 15.63 | 15.37 | 15.55 | 27,747 | |
10/29/2024 | 15.85 | 16.16 | 15.70 | 15.70 | 29,146 | |
10/28/2024 | 16.25 | 16.61 | 15.88 | 15.89 | 61,152 | |
10/25/2024 | 16.18 | 16.81 | 16.18 | 16.52 | 39,700 | |
10/24/2024 | 16.37 | 16.37 | 16.03 | 16.15 | 16,650 | |
10/23/2024 | 16.28 | 16.99 | 16.25 | 16.48 | 18,673 | |
10/22/2024 | 16.71 | 16.96 | 16.42 | 16.43 | 21,201 | |
10/21/2024 | 16.24 | 16.92 | 16.18 | 16.50 | 35,115 | |
10/18/2024 | 16.36 | 16.58 | 16.12 | 16.54 | 33,043 | |
10/17/2024 | 16.98 | 17.16 | 16.50 | 16.51 | 23,246 | |
10/16/2024 | 16.98 | 17.11 | 16.69 | 17.00 | 24,368 | |
10/15/2024 | 17.99 | 17.99 | 16.79 | 17.05 | 45,778 | |
10/11/2024 | 17.63 | 18.36 | 17.63 | 17.89 | 50,876 | |
10/10/2024 | 16.47 | 17.82 | 16.47 | 17.63 | 75,769 | |
10/09/2024 | 16.85 | 17.20 | 16.37 | 16.45 | 53,809 | |
10/08/2024 | 16.06 | 17.47 | 16.06 | 16.88 | 87,502 | |
10/07/2024 | 15.77 | 16.03 | 15.64 | 16.03 | 27,670 | |
10/04/2024 | 15.46 | 16.07 | 15.46 | 15.75 | 41,300 | |
10/03/2024 | 15.02 | 15.84 | 15.02 | 15.46 | 58,123 | |
10/02/2024 | 14.79 | 15.25 | 14.73 | 14.95 | 50,994 | |
10/01/2024 | 15.25 | 15.25 | 14.43 | 14.69 | 70,184 | |
09/30/2024 | 14.62 | 15.35 | 14.53 | 15.24 | 87,276 | |
09/27/2024 | 13.38 | 14.83 | 13.31 | 14.53 | 145,057 | |
09/26/2024 | 14.29 | 14.29 | 13.03 | 13.28 | 170,294 | |
09/25/2024 | 14.53 | 14.75 | 14.23 | 14.25 | 40,710 | |
09/24/2024 | 14.63 | 14.74 | 14.21 | 14.50 | 53,800 | |
09/23/2024 | 14.34 | 15.15 | 14.34 | 14.79 | 44,305 | |
09/20/2024 | 15.05 | 15.05 | 14.28 | 14.61 | 70,501 | |
09/19/2024 | 15.60 | 15.65 | 14.72 | 15.12 | 62,278 | |
09/18/2024 | 15.27 | 15.71 | 15.18 | 15.53 | 69,965 | |
09/17/2024 | 14.56 | 16.05 | 14.52 | 15.64 | 124,500 |
About Cipher Pharmaceuticals Stock history
Cipher Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cipher is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cipher Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cipher Pharmaceuticals stock prices may prove useful in developing a viable investing in Cipher Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 25.4 M | 32.1 M | |
Net Income Applicable To Common Shares | 30.6 M | 32.2 M |
Cipher Pharmaceuticals Quarterly Net Working Capital |
|
Cipher Pharmaceuticals Stock Technical Analysis
Cipher Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
All Next | Launch Module |
Cipher Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cipher Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Cipher Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cipher to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.20) | |||
Total Risk Alpha | (0.83) | |||
Treynor Ratio | 1.38 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Other Information on Investing in Cipher Stock
Cipher Pharmaceuticals financial ratios help investors to determine whether Cipher Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cipher with respect to the benefits of owning Cipher Pharmaceuticals security.